Orion Biotech Opportunities Corp. (ORIA) Research

Orion Biotech Opportunities Corp. functions as a blank check company, meaning its primary goal is to undertake a business combination – such as a merger, acquisition of assets or shares, or a corporate reorganization – with one or more existing businesses. Established in 2021, the company is headquartered in New York, New York.

Market snapshot

Symbol
ORIA
Price
$10.23
Day change
0.00%
Market cap
$201.0M
P/E ratio
11.11x
52-week range
9.71-12.0
Sector
Financial Services
Industry
Shell Companies

Peer companies

  • Alpha Partners Technology Merger Corp. (APTM)
  • Build Acquisition Corp. (BGSX)
  • Corazon Capital V838 Monoceros Corp (CRZN)
  • Frontier Acquisition Corp. (FRON)
  • Green Visor Financial Technology Acquisition Corp. I (GVCI)
  • TB S.A. Acquisition Corp (TBSA)
  • TortoiseEcofin Acquisition Corp. III (TRTL)

Recent insider activity

  • Orion Sponsor Holdings, LLC — D-Return (4879999 shares) on 2023-05-17
  • Broder Samuel — D-Return (40000 shares) on 2023-05-17
  • Collins James J. — D-Return (40000 shares) on 2023-05-17
  • Rodriguez Louisa — D-Return (40000 shares) on 2023-05-17
  • Orion Sponsor Holdings, LLC — J-Other (750000 shares) on 2021-06-25

Open Orion Biotech Opportunities Corp. (ORIA) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.